Chemours (NYSE:CC) Lifted to “Buy” at StockNews.com

StockNews.com upgraded shares of Chemours (NYSE:CCGet Rating) from a hold rating to a buy rating in a research note released on Tuesday.

CC has been the topic of a number of other research reports. UBS Group boosted their target price on Chemours from $35.00 to $37.00 and gave the company a neutral rating in a research note on Friday, July 29th. Barclays upped their price target on Chemours from $30.00 to $34.00 in a research note on Tuesday, November 1st. The Goldman Sachs Group began coverage on Chemours in a research note on Thursday, October 13th. They set a neutral rating and a $30.00 price target for the company. Argus downgraded Chemours from a buy rating to a hold rating in a research note on Wednesday, October 5th. Finally, Citigroup upped their price target on Chemours to $30.00 in a research note on Thursday, October 27th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of Hold and a consensus target price of $33.00.

Chemours Stock Performance

Shares of CC stock opened at $32.84 on Tuesday. Chemours has a 1-year low of $22.56 and a 1-year high of $44.95. The company has a current ratio of 1.82, a quick ratio of 1.14 and a debt-to-equity ratio of 2.73. The company has a market capitalization of $4.96 billion, a price-to-earnings ratio of 5.85, a P/E/G ratio of 0.55 and a beta of 1.86. The stock’s fifty day simple moving average is $28.98 and its 200-day simple moving average is $33.53.

Chemours (NYSE:CCGet Rating) last issued its quarterly earnings results on Tuesday, October 25th. The specialty chemicals company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.08. Chemours had a return on equity of 73.45% and a net margin of 12.91%. The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company posted $1.27 earnings per share. Chemours’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, sell-side analysts predict that Chemours will post 4.93 earnings per share for the current fiscal year.

Chemours Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Investors of record on Tuesday, November 15th will be given a dividend of $0.25 per share. The ex-dividend date is Monday, November 14th. This represents a $1.00 annualized dividend and a dividend yield of 3.05%. Chemours’s dividend payout ratio is presently 17.83%.

Hedge Funds Weigh In On Chemours

Several large investors have recently added to or reduced their stakes in CC. Asset Management One Co. Ltd. acquired a new position in Chemours in the 2nd quarter valued at approximately $25,000. CNB Bank acquired a new position in Chemours in the 2nd quarter valued at approximately $25,000. Prospera Financial Services Inc acquired a new position in Chemours in the 1st quarter valued at approximately $29,000. Dravo Bay LLC acquired a new position in shares of Chemours in the 1st quarter worth approximately $34,000. Finally, Trust Co. of Vermont acquired a new position in shares of Chemours in the 2nd quarter worth approximately $35,000. Institutional investors and hedge funds own 70.86% of the company’s stock.

Chemours Company Profile

(Get Rating)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Read More

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.